# RELAXaHEAD for Headache Patients (Phase I)

> **NCT03183791** · NA · COMPLETED · sponsor: **NYU Langone Health** · enrollment: 402 (actual)

## Conditions studied

- Headache
- Migraine
- Multiple Sclerosis

## Interventions

- **BEHAVIORAL:** RELAXaHEAD app
- **BEHAVIORAL:** Monitored Usual Care (MUC)

## Key facts

- **NCT ID:** NCT03183791
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-01
- **Primary completion:** 2019-05-25
- **Final completion:** 2019-05-25
- **Target enrollment:** 402 (ACTUAL)
- **Last updated:** 2022-07-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03183791

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03183791, "RELAXaHEAD for Headache Patients (Phase I)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03183791. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*